Changes to anti-JCV antibody levels in a Swedish national MS cohort.

J Neurol Neurosurg Psychiatry · 2013 · PMC3812878 · PMID 23463870

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The relatively high proportion of patients who increased in anti-JCV antibody titres during IFN therapy, and the low statistical power due to the low number of PML patients included, explain why only the IFN2-subgroup differed from the PML patients, while the IFN1-subgroup showed the same trend, but did not reach statistical significance (see online supplementary efigure S2B).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.